News
Pfizer and BioNTech to Supply Japan with 120 Million Doses of their BNT162 mRNA-based Vaccine Candidate
Pfizer Inc and BioNTech SE announced an agreement with the Ministry of Health, Labour and Welfare (MHLW) in Japan to supply 120 million doses of BNT162 mRNA-based vaccine candidate against SARS-CoV2, subject to clinical success and regulatory approval, beginning...
News
Sanofi and GSK in advanced discussions with European Union to supply up to 300 million doses of COVID-19 vaccine
Sanofi and GSK are in advanced discussions, with the European Commission (EC) for the supply of up to 300 million doses of a COVID-19 vaccine. The vaccine candidate developed by Sanofi in partnership with GSK, is based on the...
News
Over 300 Clinical Studies Benefit from CluePoints COVID-19 Risk Management Support
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, announced the success of its complimentary COVID-19 risk management package alongside comprehensive support for COVID-19 affected trials. Launched in April in the...
News
Abzena appoints Matthew LeClair as SVP and Site Head of San Diego Operations
Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Matthew LeClair as Senior Vice President (SVP) and Site Head of its San Diego Operations.
With...
News
Biocair Expands US Presence And Capacity
With the expansion of two of Biocair’s North American facilities, the company’s offerings in the US have increased substantially.
The Philadelphia office has doubled in size, with a state-of-the-art cryogenic filling station to further support cell and gene therapy...
News
Pharmapack Moves to May 2021
Pharmapack Europe, organised by Informa Markets, moves to May 2021 (19-20) to provide attendees, exhibitors and the pharma packaging community the best season and format. The decision follows a careful review with key stakeholders, with the exhibition continuing at...
News
FDA Grants Emergency Use Authorization for Eli Lilly, Sandia National Labs Coronavirus PCR Tests
The US FDA granted separate Emergency Use Authorizations for PCR-based SARS-CoV-2 tests developed by Eli Lilly and Sandia National Laboratories.
The Lilly SARS-CoV-2 Assay is designed to detect the virus' nucleocapsid gene in nasopharyngeal, oropharyngeal, anterior nasal, and midturbinate swabs,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.